Evidence brief · Supplement

Sage for Cognition in dementia

Evidence grade C — Preliminary

Overall grade
Grade C
Last revised
1
graded outcome
0
references listed

Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.

1 at grade C — 1 graded row

What is known

Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.

  • Cognition in dementiaEvidence grade C

    Preliminary

    Smalllow

What is uncertain

Read off the same rows as above. Nothing here is added that the entry does not itself record.

  • Thin evidence: Cognition in dementia (grade C).

The evidence in words

The verdict

For cognition in dementia, Sage earns evidence grade C (small effect, low consistency) — the evidence is limited or mixed. Preliminary

How it might work

Sage inhibits acetylcholinesterase and has antioxidant activity relevant to cognition.

How to use it

Standardized extract acutely for cognitive tasks; dosing per product.

Safety & cautions

Generally safe at supplemental doses; avoid high-thujone forms in pregnancy.

Bottom line

A pleasant, low-risk acute cognitive aid with small but repeatable effects. Standardized extract before demanding tasks.

How it is used

As the entry records it, from the studies it summarises. Not a recommendation for you — doses that suit a trial population may not suit you.

Standard
Standardized extract, acute.

Goes with

  • SageRead the full Sage monographEvidence grade C

Entries that share this one's tags or conditions.

Sources

This entry lists no references of its own — it is assembled from the entries it links to, whose sources are on their pages.

Last revised . A grade is this entry's reading of the evidence, not medical advice.